The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1

河马信号通路 生物 癌症研究 癌基因 转录因子 雅普1 激酶 癌症 免疫系统 PD-L1 细胞生物学 细胞周期 免疫学 基因 遗传学 免疫疗法
作者
Helena J. Janse van Rensburg,Taha Azad,Min Ling,Yawei Hao,Brooke Snetsinger,Prem Khanal,Lori M. Minassian,Charles H. Graham,Michael J. Rauh,Xiaolong Yang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:78 (6): 1457-1470 被引量:307
标识
DOI:10.1158/0008-5472.can-17-3139
摘要

Abstract The Hippo pathway component WW domain-containing transcription regulator 1 (TAZ) is a transcriptional coactivator and an oncogene in breast and lung cancer. Transcriptional targets of TAZ that modulate immune cell function in the tumor microenvironment are poorly understood. Here, we perform a comprehensive screen for immune-related genes regulated by TAZ and its paralog YAP using NanoString gene expression profiling. We identify the immune checkpoint molecule PD-L1 as a target of Hippo signaling. The upstream kinases of the Hippo pathway, mammalian STE20-like kinase 1 and 2 (MST1/2), and large tumor suppressor 1 and 2 (LATS1/2), suppress PD-L1 expression while TAZ and YAP enhance PD-L1 levels in breast and lung cancer cell lines. PD-L1 expression in cancer cell lines is determined by TAZ activity and TAZ/YAP/TEAD increase PD-L1 promoter activity. Critically, TAZ-induced PD-L1 upregulation in human cancer cells is sufficient to inhibit T-cell function. The relationship between TAZ and PD-L1 is not conserved in multiple mouse cell lines, likely due to differences between the human and mouse PD-L1 promoters. To explore the extent of divergence in TAZ immune-related targets between human and mouse cells, we performed a second NanoString screen using mouse cell lines. We show that many targets of TAZ may be differentially regulated between these species. These findings highlight the role of Hippo signaling in modifying human/murine physiologic/pathologic immune responses and provide evidence implicating TAZ in human cancer immune evasion. Significance: Human-specific activation of PD-L1 by a novel Hippo signaling pathway in cancer immune evasion may have a significant impact on research in immunotherapy. Cancer Res; 78(6); 1457–70. ©2018 AACR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero的应助被科研通管家采纳,获得10
刚刚
研友_VZG7GZ的应助被科研通管家采纳,获得10
刚刚
yang_f完成签到,获得积分10
刚刚
wq完成签到,获得积分10
刚刚
刚刚
刚刚
Wyy321的应助被科研通管家采纳,获得10
1秒前
山神与你有约完成签到,获得积分10
1秒前
HJJHJH的应助被科研通管家采纳,获得30
1秒前
1秒前
YuJue的应助被科研通管家采纳,获得30
1秒前
打打的应助被科研通管家采纳,获得10
1秒前
小二郎的应助被科研通管家采纳,获得10
1秒前
1秒前
香蕉觅云的应助被科研通管家采纳,获得10
1秒前
2秒前
火星上秋烟完成签到,获得积分10
2秒前
夏渃浠完成签到,获得积分10
2秒前
LS完成签到,获得积分10
2秒前
jiliu482发布了新的文献求助10
2秒前
fan完成签到,获得积分10
2秒前
2秒前
追寻的谷波完成签到,获得积分10
3秒前
我爱科研完成签到,获得积分10
3秒前
勤奋帅帅完成签到,获得积分10
3秒前
Jim完成签到,获得积分10
3秒前
与可完成签到,获得积分10
4秒前
尊敬寒松完成签到 ,获得积分10
4秒前
如初完成签到,获得积分10
4秒前
轩扬完成签到,获得积分10
5秒前
顺利翠萱完成签到,获得积分10
5秒前
5秒前
材料k完成签到,获得积分10
5秒前
天天向上的应助被梁潇鸿采纳,获得10
5秒前
5秒前
solar@2030发布了新的文献求助10
6秒前
ypljk完成签到,获得积分10
6秒前
背后迎夏完成签到 ,获得积分10
6秒前
Farrell完成签到 ,获得积分10
7秒前
听话的寒天完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039